Table 1.
Patients Characteristics and Operative Data
| Clinical Characteristics | Covid n = 23 | Non-Covid n = 46 | p Value |
|---|---|---|---|
| Age (mean ± SD), y | 68.7 ± 8.3 | 67 ± 12.6 | 0.1 |
| Female patients n (%) | 4 (17) | 11 (24) | 0.5 |
| BMI (mean ± SD), Kg/m2 | 26.6 ± 2 | 26.8 ± 3.4 | 0.1 |
| Hypertension, n (%) | 20 (87) | 36 (78.2) | 0.3 |
| Diabetes, n (%) | 9 (39) | 7 (15) | *0.02 |
| Dyslipidemia, n (%) | 11 (48) | 33 (72) | 0.05 |
| Smoking habit, n (%) | 9 (39) | 17 (37) | 0.8 |
| Renal failure, n (%) | 4(17) | 2 (4) | 0.06 |
| COPD, n (%) | 7 (30) | 6 (13) | 0.08 |
| Previous NV events, n (%) | 3 (13) | 1 (2) | 0.06 |
| PVD, n (%) | 6 (26) | 4 (9) | 0.05 |
| Emergent operation, n (%) | 3 (13) | 3 (6) | 0.3 |
| CABG isolated, n (%) | 7 (30) | 19 (41) | - |
| AAR, n (%) | 1 (4) | 2 (4) | - |
| AV surgery, n (%) | 1 (4) | 6 (13) | - |
| MV (± TV) surgery, n (%) | 5 (22) | 7 (15) | - |
| MV + AV (± TV) surgery, n (%) | 2 (9) | 0 (0) | - |
| AV or MV + CABG, n (%) | 0 (0) | 4 (9) | - |
| AAR + CABG, n (%) | 1 (4) | 2 (4) | - |
| AAR + AV surgery, n (%) | 3 (13) | 5 (11) | - |
| AVPL + AAR + CABG, n (%) | 2 (9) | 0 (0) | - |
| AVPL+ AAR + ER, n (%) | 1(4) | 1 (2) | - |
| Ministernotomy, n (%) | 4 (17) | 9 (19) | 0.8 |
| Infective endocarditis, n (%) | 1 (4) | 1 (2) | 0.6 |
| EF (mean ± SD) % | 56 ± 7 | 55 ± 8 | 0.4 |
| STS score-morbidity/mortality (mean ± SD) % | 11 ± 6.9 | 8.1 ± 5.8 | 0.3 |
| CPB time, (mean ± SD) min | 152 ± 79 | 130 ± 45 | 0.08 |
| Aortic cross-clamp time (mean ± SD) min | 106 ± 36 | 86 ± 27 | 0.07 |
| SHT (mean ± SD) min | 81 ± 56 | 64 ± 45 | *0.0003 |
| ACT pre-CPB (mean ± SD) s | 490 ± 87 | 483 ± 142 | 0.05 |
| ACT post-CPB (mean ± SD) s | 509 ± 140 | 425 ± 181 | 0.1 |
Abbreviations: AAR, ascending aorta replacement; ACT, activated clotting time; AV, aortic valve; BMI, body mass index; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; CPB, cardiopulmonary bypass; EF, ejection fraction; ER, emiarch replacement; MV, mitral valve; NV, neurovascular; PVD, peripheral vascular disease; TV, tricuspid valve; SD, standard deviation; SHT, surgical hemostasis time; STS score, Society of Thoracic Surgeons.
⁎
p < 0.05.